OA08039A - 3,4-diamido-1,2,5-thiadiazoles substitués présentant une activité antagoniste du récepteur H2 de l'histamine. - Google Patents

3,4-diamido-1,2,5-thiadiazoles substitués présentant une activité antagoniste du récepteur H2 de l'histamine.

Info

Publication number
OA08039A
OA08039A OA58614A OA58614A OA08039A OA 08039 A OA08039 A OA 08039A OA 58614 A OA58614 A OA 58614A OA 58614 A OA58614 A OA 58614A OA 08039 A OA08039 A OA 08039A
Authority
OA
OAPI
Prior art keywords
diamido
thiadiazoles
substituted
receptor antagonist
antagonist activity
Prior art date
Application number
OA58614A
Other languages
English (en)
Inventor
Aldo A Algieri
Ronnie R Crenshaw
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of OA08039A publication Critical patent/OA08039A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
OA58614A 1984-06-22 1985-08-18 3,4-diamido-1,2,5-thiadiazoles substitués présentant une activité antagoniste du récepteur H2 de l'histamine. OA08039A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/623,588 US4644006A (en) 1984-06-22 1984-06-22 Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity

Publications (1)

Publication Number Publication Date
OA08039A true OA08039A (fr) 1987-01-31

Family

ID=24498651

Family Applications (1)

Application Number Title Priority Date Filing Date
OA58614A OA08039A (fr) 1984-06-22 1985-08-18 3,4-diamido-1,2,5-thiadiazoles substitués présentant une activité antagoniste du récepteur H2 de l'histamine.

Country Status (33)

Country Link
US (1) US4644006A (fr)
JP (2) JPS6118775A (fr)
KR (1) KR900004321B1 (fr)
AR (1) AR240935A1 (fr)
AT (1) AT390790B (fr)
AU (2) AU580605B2 (fr)
BE (1) BE902724A (fr)
CA (2) CA1267412A (fr)
CH (1) CH665210A5 (fr)
CS (1) CS257276B2 (fr)
DD (1) DD240889A5 (fr)
DE (1) DE3522101A1 (fr)
DK (1) DK282885A (fr)
ES (2) ES8702902A1 (fr)
FI (1) FI852405L (fr)
FR (1) FR2566406B1 (fr)
GB (2) GB2161157B (fr)
GR (1) GR851514B (fr)
HU (1) HU193992B (fr)
IE (2) IE58261B1 (fr)
IL (1) IL75567A0 (fr)
IT (1) IT1190372B (fr)
LU (1) LU85969A1 (fr)
NL (1) NL8501766A (fr)
NO (1) NO161856C (fr)
NZ (1) NZ212403A (fr)
OA (1) OA08039A (fr)
PT (1) PT80684B (fr)
SE (1) SE464305B (fr)
SU (1) SU1537136A3 (fr)
YU (2) YU45725B (fr)
ZA (1) ZA854710B (fr)
ZW (1) ZW10385A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0535227A4 (en) * 1990-05-29 1993-08-18 Nippon Soda Co., Ltd. N-substituted heterocyclic amidine derivative
EP4196793A1 (fr) 2020-08-11 2023-06-21 Université de Strasbourg Bloqueurs de h2 ciblant des macrophages du foie pour la prévention et le traitement d'une maladie du foie et du cancer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657237A (en) * 1968-05-22 1972-04-18 Frosst & Co Charles E Process for making 1 2 5-thiadiazoles in the sinister configuration
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
EP0040696B1 (fr) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazoles comme inhibiteurs de la sécrétion gastrique
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
DE3168031D1 (en) * 1980-07-30 1985-02-14 Ici Plc Guanidine derivatives
EP0060730A3 (fr) * 1981-03-18 1982-12-08 Imperial Chemical Industries Plc Dérivés bicycliques
EP0065823A1 (fr) * 1981-05-13 1982-12-01 Imperial Chemical Industries Plc Dérivés hétérocycliques de guanidine, comme antagonistes de histamine H-2
US4528375A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
ZW7683A1 (en) * 1982-03-29 1984-01-04 Bristol Myers Co Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h2 receptor antagonist activity
US4528377A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4517366A (en) * 1982-03-29 1985-05-14 Bristol-Myers Company Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles
US4528378A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4588826A (en) * 1982-03-29 1986-05-13 Bristol-Myers Company Ethanediimidamide intermediates
FI832519L (fi) * 1982-07-12 1984-01-13 Bristol Myers Co Farmaceutiska foerfaranden och sammansaettningar
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
JPS5978171A (ja) * 1982-10-26 1984-05-04 Ikeda Mohandou:Kk 複素環式化合物
US4440933A (en) * 1983-03-16 1984-04-03 Bristol-Myers Company Process for preparing 1,2,5-thiadiazoles

Also Published As

Publication number Publication date
AU2977589A (en) 1989-06-01
CA1267412A (fr) 1990-04-03
IT8521217A0 (it) 1985-06-20
SE8503110D0 (sv) 1985-06-20
GB8716149D0 (en) 1987-08-12
CS424785A2 (en) 1987-09-17
GR851514B (fr) 1985-11-25
IL75567A0 (en) 1985-10-31
DK282885D0 (da) 1985-06-21
SU1537136A3 (ru) 1990-01-15
YU105185A (en) 1987-12-31
HUT42087A (en) 1987-06-29
AT390790B (de) 1990-06-25
YU102587A (en) 1988-02-29
SE464305B (sv) 1991-04-08
IE58261B1 (en) 1993-08-25
LU85969A1 (fr) 1986-01-24
GB2192884A (en) 1988-01-27
CH665210A5 (de) 1988-04-29
FR2566406B1 (fr) 1988-01-29
NL8501766A (nl) 1986-01-16
NO161856C (no) 1989-10-04
AU4392085A (en) 1986-01-02
NO852519L (no) 1985-12-23
YU45822B (sh) 1992-07-20
IE851557L (en) 1985-12-22
JPS6118775A (ja) 1986-01-27
FI852405A0 (fi) 1985-06-17
ES544409A0 (es) 1987-01-16
FI852405L (fi) 1985-12-23
ES8702902A1 (es) 1987-01-16
KR860000275A (ko) 1986-01-27
CS257276B2 (en) 1988-04-15
GB2161157A (en) 1986-01-08
BE902724A (fr) 1985-12-23
GB2192884B (en) 1988-08-10
US4644006A (en) 1987-02-17
JPS61186369A (ja) 1986-08-20
ZW10385A1 (en) 1986-02-05
AR240935A2 (es) 1991-03-27
KR900004321B1 (ko) 1990-06-22
NZ212403A (en) 1989-04-26
AU614331B2 (en) 1991-08-29
CA1297875C (fr) 1992-03-24
IT1190372B (it) 1988-02-16
ATA185885A (de) 1989-12-15
ZA854710B (en) 1986-02-26
AU580605B2 (en) 1989-01-19
DE3522101A1 (de) 1986-01-02
SE8503110L (sv) 1985-12-23
AR240935A1 (es) 1991-03-27
GB8515749D0 (en) 1985-07-24
YU45725B (sh) 1992-07-20
FR2566406A1 (fr) 1985-12-27
IE57937B1 (en) 1993-05-19
NO161856B (no) 1989-06-26
PT80684A (en) 1985-07-01
HU193992B (en) 1987-12-28
ES551506A0 (es) 1987-01-16
DK282885A (da) 1985-12-23
DD240889A5 (de) 1986-11-19
GB2161157B (en) 1988-08-10
PT80684B (en) 1987-05-08
ES8702881A1 (es) 1987-01-16

Similar Documents

Publication Publication Date Title
DE3574665D1 (de) Glutamatrezeptorshemmstoff.
OA07791A (fr) Pyridines 2,5-Substituées Substituées.
NO852561L (no) Farmakologisk aktive, substituerte benzamider.
FI854957A (fi) Bentonit innehaollande, mjukgoerande, flytande tvaettmedel foer textiler.
DE3579895D1 (de) Senderempfaenger.
DE3772122D1 (de) Substituierte 1,5-benzodiazepin-derivate.
DE3585873D1 (de) Vinylbenzyl-2,2,6,6-tetramethylpiperidine.
DE3777538D1 (de) Wolfram metallisierung.
OA07356A (fr) 3,4-Diamino-1,2,5-thiadiazoles substitués possedant une activité antagoniste du récepteur-H2 de l'histamine.
OA08039A (fr) 3,4-diamido-1,2,5-thiadiazoles substitués présentant une activité antagoniste du récepteur H2 de l'histamine.
IT8422150A0 (it) Composti dotati di attivita'antiallergica.
DE69004455T2 (de) Alpha-adrenergene Rezeptor-Antagonisten.
IT8422744A0 (it) 4(3h)-pirimidoni 2,5-disostituiti aventi attivita' antagonista dei recettori della istamina h2.
NO164153C (no) Soetningsmiddel med lavt kaloriinnhold.
DE69004827D1 (de) Alpha-adrenergene Rezeptor-Antagonisten.
IT8419413A0 (it) Composti imidazopiridinici farmacologicamente attivi.
ATE30018T1 (de) Leukotrien-antagonisten.
IT8622736A0 (it) Antagonisti dell'aldosterone.
IT8422446A0 (it) Composti farmacologicamente attivi.
IT8422702A0 (it) Nuovi 2,3-diidro-1,4-benzodiossini 2,2-disostituiti ad attivita'ipotensiva.
IT8423967A0 (it) Composti eterociclici dotati di attivita' terapeutica.
IT8420545V0 (it) Struttura di cannuccia multiuso.
FI841392A0 (fi) Kudde, luftkonditionerad med en oeppning.
ATE41928T1 (de) Phenylbenzoylharnstoffe.
IT8323109A0 (it) Nuovi 2,3-diidro-1,4-benzodiossini 2,2-disostituiti ad attivita'ipotensiva.